RDUS
Income statement / Annual
Last year (2023), Radius Health, Inc.'s total revenue was $2.88 B,
a decrease of 17.32% from the previous year.
In 2023, Radius Health, Inc.'s net income was -$25.79 M.
See Radius Health, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
08/31/2023 |
08/31/2022 |
08/31/2021 |
08/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$2.88 B
|
$3.49 B
|
$2.76 B
|
$1.71 B
|
$173.32 M
|
$99.24 M
|
$22.11 M
|
$0.00
|
$0.00
|
$0.00
|
Cost of Revenue |
$2.57 B |
$3.00 B |
$2.31 B |
$1.50 B |
$16.09 M |
$8.43 M |
$1.33 M |
$0.00 |
$0.00 |
$0.00 |
Gross Profit |
$307.71 M |
$488.07 M |
$453.19 M |
$208.62 M |
$157.23 M |
$90.81 M |
$20.78 M |
$0.00 |
$0.00 |
$0.00 |
Gross Profit Ratio |
0.11 |
0.14 |
0.16 |
0.12 |
0.91 |
0.92 |
0.94 |
0 |
0 |
0 |
Research and Development
Expenses |
$0.00
|
$0.00
|
$134.63 M
|
$159.71 M
|
$116.76 M
|
$99.91 M
|
$83.08 M
|
$107.41 M
|
$68.28 M
|
$45.72 M
|
General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$144.15 M
|
$152.70 M
|
$184.16 M
|
$186.68 M
|
$77.54 M
|
$30.80 M
|
$13.67 M
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$43.72 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$265.93 M
|
$263.26 M
|
$242.46 M
|
$187.88 M
|
$152.70 M
|
$184.16 M
|
$186.68 M
|
$77.54 M
|
$30.80 M
|
$13.67 M
|
Other Expenses |
-$5.56 M |
-$692,000.00 |
-$455,000.00 |
-$124,000.00 |
$0.00 |
$10.80 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Operating Expenses |
$265.93 M |
$263.26 M |
$242.46 M |
$187.88 M |
$269.46 M |
$294.88 M |
$269.75 M |
$184.95 M |
$99.08 M |
$59.39 M |
Cost And Expenses |
$2.84 B |
$3.26 B |
$2.55 B |
$1.69 B |
$285.55 M |
$303.30 M |
$271.09 M |
$184.95 M |
$99.08 M |
$59.39 M |
Interest Income |
$0.00 |
$0.00 |
$75,000.00 |
$1.40 M |
$3.93 M |
$5.62 M |
$3.23 M |
$2.44 M |
$1.04 M |
$94,000.00 |
Interest Expense |
$18.59 M |
$8.54 M |
$5.29 M |
$8.67 M |
$24.36 M |
$22.45 M |
$8.30 M |
$0.00 |
$1.89 M |
$2.47 M |
Depreciation &
Amortization |
$89.76 M
|
$75.05 M
|
$58.60 M
|
$58.17 M
|
$2.31 M
|
$2.87 M
|
$1.95 M
|
$586,000.00
|
$176,000.00
|
$77,000.00
|
EBITDA |
$38.31 M
|
$226.86 M
|
$214.28 M
|
$21.45 M
|
-$106.32 M
|
-$196.02 M
|
-$243.99 M
|
-$182.22 M
|
-$99.47 M
|
-$59.94 M
|
EBITDA Ratio |
0.01 |
0.07 |
0.08 |
0.01 |
-0.61 |
-1.98 |
-11.03 |
0 |
0 |
0 |
Operating Income Ratio
|
-0
|
0.06
|
0.08
|
0
|
-0.65
|
-2.06
|
-11.26
|
0
|
0
|
0
|
Total Other
Income/Expenses Net |
-$51.27 M
|
$401,000.00
|
$2.54 M
|
-$14.01 M
|
-$20.76 M
|
-$17.27 M
|
-$5.26 M
|
$2.14 M
|
-$2.45 M
|
-$3.09 M
|
Income Before Tax |
-$28.08 M |
$216.68 M |
$207.99 M |
-$1.94 M |
-$132.99 M |
-$221.34 M |
-$254.24 M |
-$182.80 M |
-$101.53 M |
-$62.48 M |
Income Before Tax Ratio
|
-0.01
|
0.06
|
0.08
|
-0
|
-0.77
|
-2.23
|
-11.5
|
0
|
0
|
0
|
Income Tax Expense |
-$2.75 M |
$44.60 M |
$37.94 M |
$166,000.00 |
$3.60 M |
$5.18 M |
$3.03 M |
$2.14 M |
-$564,000.00 |
-$619,000.00 |
Net Income |
-$25.79 M |
$168.80 M |
$165.11 M |
-$4.15 M |
-$132.99 M |
-$221.34 M |
-$254.24 M |
-$182.80 M |
-$101.53 M |
-$62.48 M |
Net Income Ratio |
-0.01 |
0.05 |
0.06 |
-0 |
-0.77 |
-2.23 |
-11.5 |
0 |
0 |
0 |
EPS |
-0.92 |
6.01 |
5.9 |
-0.15 |
-2.89 |
-4.88 |
-5.8 |
-4.24 |
-2.56 |
-3.53 |
EPS Diluted |
-0.92 |
5.72 |
5.66 |
-0.15 |
-2.89 |
-4.88 |
-5.8 |
-4.24 |
-2.56 |
-3.53 |
Weighted Average Shares
Out |
$28.01 M
|
$28.08 M
|
$27.98 M
|
$27.67 M
|
$46.03 M
|
$45.36 M
|
$43.80 M
|
$43.07 M
|
$39.64 M
|
$17.70 M
|
Weighted Average Shares
Out Diluted |
$28.01 M
|
$29.53 M
|
$29.19 M
|
$27.67 M
|
$46.03 M
|
$45.36 M
|
$43.80 M
|
$43.07 M
|
$39.64 M
|
$17.70 M
|
Link |
|
|
|
|
|
|
|
|
|
|